IMO funding for phase 3 has to be some form of partnership, this thing a aren't cheap. By partnership I mean even a big investor not necessarily pharma. I'm invested in a couple biotechs in the states and their partners are Morgan Stanley, Goldman Sachs etc. as well as pharma. Just someone with deeps pockets.
Ann: CEO's Address to Shareholders, page-7
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $247.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5988 | 45.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.5¢ | 1500 | 1 |
View Market Depth
| Last trade - 09.54am 04/09/2024 (20 minute delay) ? |
| DXB (ASX) Chart |
Day chart unavailable